Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
To access this article, please choose from the options below
PII: S0920-9964(07)00191-0
doi:10.1016/j.schres.2007.04.035
© 2007 Elsevier B.V. All rights reserved.
